Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

227 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta.
Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Anticancer Drugs. 1996 Nov;7(8):838-45. doi: 10.1097/00001813-199611000-00004. Anticancer Drugs. 1996. PMID: 8991187
Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression.
Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Anticancer Drugs. 1998 Apr;9(4):311-7. doi: 10.1097/00001813-199804000-00004. Anticancer Drugs. 1998. PMID: 9635921
Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M. Bertram J, et al. Biochem Biophys Res Commun. 1994 Apr 15;200(1):661-7. doi: 10.1006/bbrc.1994.1499. Biochem Biophys Res Commun. 1994. PMID: 7909438
Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
Palfner K, Kneba M, Hiddemann W, Bertram J. Palfner K, et al. Biol Chem Hoppe Seyler. 1995 May;376(5):289-95. doi: 10.1515/bchm3.1995.376.5.289. Biol Chem Hoppe Seyler. 1995. PMID: 7544982
Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.
Kneba M, Eick S, Herbst H, Willigeroth S, Pott C, Bolz I, Bergholz M, Neumann C, Stein H, Krieger G. Kneba M, et al. Cancer Res. 1991 Jun 15;51(12):3243-50. Cancer Res. 1991. PMID: 2039999
Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR.
Bertram J, Palfner K, Hiddemann W, Kneba M. Bertram J, et al. Eur J Cancer. 1998 Apr;34(5):731-6. doi: 10.1016/s0959-8049(97)10081-8. Eur J Cancer. 1998. PMID: 9713282
Heterogeneity of immunoglobulin gene rearrangements in B-cell lymphomas.
Kneba M, Bergholz M, Bolz I, Hulpke M, Bätge R, Schauer A, Krieger G. Kneba M, et al. Int J Cancer. 1990 Apr 15;45(4):609-13. doi: 10.1002/ijc.2910450406. Int J Cancer. 1990. PMID: 2157671
Clinical characteristics of high-grade lymphomas with immune genes in germline configuration.
Kneba M, Bolz I, Bergholz M, Bätge R, Nauck M, Nitsche R, Krieger G. Kneba M, et al. Cancer. 1991 Feb 1;67(3):603-9. doi: 10.1002/1097-0142(19910201)67:3<603::aid-cncr2820670314>3.0.co;2-p. Cancer. 1991. PMID: 1985755
227 results
Jump to page
Feedback